Migraine Progression: A Systematic Review

Buse, Dawn C., Greisman, Jacob D., Baigi, Khosrow, Lipton, Richard B.·2019·Headache: The Journal of Head and Face Pain
DOI 10.1111/head.13459

Cited by (328)

Items 101–200 of 328

  1. Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database
    Shonda A. Foster, Chi‐Chang Chen, Yao Ding, Oksana Mason, Catherine Balderston McGuiness, Paula Morrow, Wenyu Ye, Rolin L. Wade, Timothy Ryan Smith, Shivang Joshi · 2020 · Journal of Medical Economics
  2. “Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials
    Thanin Asawavichienjinda, Seelwan Sathitratanacheewin, Ronpichai Chokesuwattanaskul · 2023 · Cephalalgia
  3. Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States
    David W. Dodick, Michael L. Reed, Lulu Lee, Bridget L. Balkaran, Kandavadivu Umashankar, Mousam Parikh, Pranav Gandhi, Dawn C. Buse · 2024 · Headache The Journal of Head and Face Pain
  4. Forecasting migraine attacks by managing daily lifestyle: a systematic review as a basis to develop predictive algorithms
    Umberto Quartetti, Filippo Brighina, Giuditta Gambino, Monica Frinchi, Marianna Bellafiore, Garden Tabacchi, Sonya Vasto, Giulia Accardi, Antonella Amato, Marta Giardina et al. · 2025 · PAIN Reports
  5. Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery
    Sunena Jha, Dinanath Mishra · 2022 · Pharmaceutical Nanotechnology
  6. An Exponential Curve Relationship Between Serum Urate and Migraine: A Cross-Section Study From NHANES
    Peiwei Hong, Yao Liu, Yang Wan, Hai Xiong, Yanming Xu · 2022 · Frontiers in Neurology
  7. Cognitive Behavioral Therapy for the Management of Episodic Migraine
    Gregory Amatrudo, Jennifer Kengetter, Susan McCrea, Megan Amatrudo · 2023 · Current Pain and Headache Reports
  8. Bio-chemical markers of chronic, non-infectious disease in the human tear film
    Sultan Alotaibi, Maria Panayiota Markoulli, Jerome Ozkan, ERIC B. PAPAS · 2021 · Clinical and Experimental Optometry
  9. Approach to Pediatric Intractable Migraine
    Mohammed A. Alqahtani, Rebecca Barmherzig, Ana Marissa Lagman‐Bartolome · 2021 · Current Neurology and Neuroscience Reports
  10. Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain
    Pamela G. Vo, Elyse Swallow, Eric Qiong Wu, Miriam L. Zichlin, Noah Katcher, Monika Maier‐Peuschel, Mariantonietta Naclerio, Daniela Ritrovato, Santosh Tiwari, Parth Joshi et al. · 2021 · Journal of Medical Economics
  11. Inter-individual differences in pain anticipation and pain perception in migraine: Neural correlates of migraine frequency and cortisol-to-dehydroepiandrosterone sulfate (DHEA-S) ratio
    Gyöngyi Kökönyei, Attila Galambos, Natália Kocsel, Edina Szabó, Andrea Edit Édes, Kinga Gecse, Dániel Baksa, Dorottya Pap, Lajos R. Kozák, György Bagdy et al. · 2021 · PLoS ONE
  12. Sex-related differences in migraine clinical features by frequency of occurrence: a cross-sectional study
    Elena Muñoz‐Gómez, Marta Aguilar Rodríguez, Pilar Serra‐Añó, Núria Sempere Rubio, Sara Mollà‐Casanova, Marta Inglés · 2023 · Scandinavian Journal of Pain
  13. Dysfunction of inhibitory interneurons contributes to synaptic plasticity via GABABR-pNR2B signaling in a chronic migraine rat model
    Xiaoxu Zeng, Yingying Niu, Guangcheng Qin, Dunke Zhang, Lixue Chen · 2023 · Frontiers in Molecular Neuroscience
  14. Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations
    Stewart J. Tepper, Huma U. Sheikh, Carrie O. Dougherty, Stephanie J. Nahas, Paul K Winner, Ananda Krishna Karanam, Andrew M. Blumenfeld, Ahmad Abdrabboh, Soeren Rasmussen, Jamie Lynn Weiss et al. · 2022 · Headache The Journal of Head and Face Pain
  15. Evaluating Plasma and Brain TRPV1 Channels in the Animal Model of Episodic and Chronic Migraine: The Possible Role of Somatosensory Cortex TRPV1 in Migraine Transformation
    Fariba Karimzadeh, Fahime Zavvari, Atousa Janzadeh, Negin Mojarad, Zeinab Ghorbani, Mansoureh Togha · 2022 · Archives of Neuroscience
  16. Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study
    Nik Krajnc, Florian Frank, Stefan Macher, Martin Michl, Nina Müller, Sarah Christine Maier, Sina Zaic, Christian Wöber, Berthold Pemp, Gregor Broessner et al. · 2024 · The Journal of Headache and Pain
  17. α7nAChR-mediated astrocytic activation: A novel mechanism of Xiongzhi Dilong decoction in ameliorating chronic migraine
    Xueqian Tang, Hao Chen, Meihuan Zhao, Wenqin Yang, Ruonan Shuang, Shijun Xu · 2024 · Journal of Ethnopharmacology
  18. Oral Chinese Herbal Medicine as Prophylactic Treatment for Episodic Migraine in Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
    Shaohua Lyu, Claire Shuiqing Zhang, Xinfeng Guo, Anthony Lin Zhang, Jingbo Sun, Chuanjian Lu, Charlie Changli Xue, Xiaodong Luo · 2020 · Evidence-based Complementary and Alternative Medicine
  19. Identification of Determinants of Biofeedback Treatment’s Efficacy in Treating Migraine and Oxidative Stress by ARIANNA (ARtificial Intelligent Assistant for Neural Network Analysis)
    Irene Ciancarelli, Giovanni Morone, Maria Giuliana Tozzi Ciancarelli, Stefano Paolucci, Paolo Tonin, Antonio Cerasa, Marco Iosa · 2022 · Healthcare
  20. Predictors of treatment‐response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti‐inflammatory drugs in acute treatment of episodic migraine
    Ali Ezzati, Kristina M. Fanning, Michael L. Reed, Richard B. Lipton · 2023 · Headache The Journal of Head and Face Pain
  21. Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine
    Andreas A. Argyriou, Emmanouil V. Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis · 2024 · Toxins
  22. Evidence Regarding Medication Overuse Headache in Children and Adolescents: Protocol for a Systematic Review
    Juliana H. VanderPluym, Jessica R. Gautreaux, Rebecca C. Burch, Evans M. Whitaker, Jason Roberts, Dana P. Turner, Amy A. Gelfand · 2020 · Headache The Journal of Head and Face Pain
  23. Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) project
    Piero Barbanti, Luisa Fofi, Licia Grazzi, Fabrizio Vernieri, Cecilia Camarda, Paola Torelli, Sabina Cevoli, Antonio Russo, Francesco Bono, Cinzia Finocchi et al. · 2021 · Headache The Journal of Head and Face Pain
  24. High rates of (treated) hypothyroidism among chronic migraine patients consulting a specialized headache clinic: are we missing something?
    Marcelo Filipchuk, Jesica Gassmann, Tatiana Castro Zamparella, Maria Cecilia Tibaldo, Mariela Carpinella, Pablo Sesto Tagliavini, Pablo Scarnato, María Teresa Goicochea, Osvaldo Carlos Bruera, Diego Martin Conci Magris et al. · 2021 · Neurological Sciences
  25. Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study
    Ali Ezzati, Kristina M. Fanning, Dawn C. Buse, Jelena M. Pavlovic, Cynthia Armand, Michael L. Reed, Vincent T. Martin, Richard B. Lipton · 2022 · Headache The Journal of Head and Face Pain
  26. Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview
    Federico Mazzacane, Gloria Vaghi, Matteo Cotta Ramusino, Giulia Perini, Alfredo Cardoso Costa · 2024 · The Journal of Headache and Pain
  27. Interoception and dissociation in migraine: a case–control study of chronic and episodic subtypes
    Akihiro Koreki, Vilomi Bhatia, Anne-Marie Logan, Usman Khan, Mitsumoto Onaya, Sarah N. Garfinkel, Hugo Critchley, Mark John Edwards, Niranjanan Nirmalananthan, Mahinda Yogarajah · 2025 · Frontiers in Neurology
  28. Transition of headache care from childhood to adulthood: Focusing needs, barriers, and models of care. A position paper of the IHS Child and Adolescent Committee
    Aynur Özge, Massimiliano Valeriani, Vincenzo Guidetti, Fumihiko Sakai, Derya Uludüz, Pınar Topaloğlu, Ishaq Abu‐Arafeh, Amy A. Gelfand, Licia Grazzi, Shuu‐Jiun Wang et al. · 2025 · Cephalalgia
  29. Short-term Treatment of Migraine in Children and Adolescents
    Irene R. Patniyot, William F. Qubty · 2020 · Archives of Pediatrics and Adolescent Medicine
  30. Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression
    Qiujun Shao, Karen L. Rascati, Kenneth A. Lawson, Jamie C. Barner, Kalyani Sonawane, Justin F. Rousseau · 2022 · Journal of Managed Care & Specialty Pharmacy
  31. Chronic migraine and medication overuse
    Hans‐Christoph Diener, Paul B. Rizzoli · 2023 · Handbook of clinical neurology
  32. Treatment effects on pain catastrophizing and cutaneous allodynia symptoms in women with migraine and overweight/obesity.
    Samantha G. Farris, John Graham Thomas, Mindy M. Kibbey, Jelena M. Pavlovic, Kristine J. Steffen, Dale S. Bond · 2020 · Health Psychology
  33. Quality Improvement in Neurology: Headache Quality Measurement Set
    Matthew Stuart Robbins, M. Cristina Victorio, Mark Bailey, Calli Leighann Cook, Ivan Garza, J. Stephen Huff, Duren Michael Ready, Nathaniel M. Schuster, David J. Seidenwurm, Elizabeth K. Seng et al. · 2020 · Headache The Journal of Head and Face Pain
  34. Need of guidance in disabling and chronic migraine identification in the primary care setting, results from the european MyLife anamnesis survey
    Ángel Luis Guerrero Peral, Andrea Negro, Philippe Ryvlin, Скоробогатых Кирилл Владимирович, Rainel Sánchez-de la Rosa, Heike Israel-Willner, Christina Sundal, E. Anne MacGregor · 2021 · BMC Family Practice
  35. The impact of migraine and probable migraine on productivity loss in Korea: A cross-sectional online survey
    Yejin Kim, Sola Han, Hae Sun Suh · 2022 · PLoS ONE
  36. Relationship of sleep quality, chronotype, and obstructive sleep apnea with migraine in the elderly population
    Asieh Kouhi Fayegh, Hazwan Mat Din, Wan Aliaa Wan Sulaiman, Maryam Ravanipour, Hamidon Basri, Mohd Hazmi Mohamed, Vasudevan Ramachandran, Liyana Najwa Inche Mat · 2023 · Neuropsychiatrie
  37. Global Epidemiology, Clinical Features, Diagnosis and Current Therapeutic Novelties in Migraine Therapy and their Prevention: A Narrative Review
    Mohammad Daud Ali, Fehmida Gayasuddin Qur, Md Sarfaraz Alam, Nawaf Alotaibi, Md Ali Mujtaba · 2023 · Current Pharmaceutical Design
  38. Real-world observations and impacts of Chinese herbal medicine for migraine: results of a registry-based cohort study
    Shaohua Lyu, Claire Shuiqing Zhang, Anthony Lin Zhang, Xinfeng Guo, Rong Hua, Zhenhui Mao, Qiaozhen Su, Charlie Changli Xue, Jingbo Sun · 2024 · Frontiers in Pharmacology
  39. A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States
    Linda A. Harris, Gilbert L’Italien, Thomas O’Connell, Zacharia Hasan, Susan L. Hutchinson, Sylvia M. Lucas · 2021 · Advances in Therapy
  40. Headache in Workers: A Matched Case–Control Study
    Reparata Rosa Di Prinzio, Gabriele Arnesano, Igor Meraglia, Nicola Magnavita · 2022 · European Journal of Investigation in Health Psychology and Education
  41. Clinical features and comorbidities associated with migraine in bipolar disorder: Results from the FACE-BD cohort
    Ludovic Samalin, Ophélia Godin, Xavier Moisset, Ambre Chalayer, Agnès Pelletier, Antoine Lefrere A, Paul Roux, Mircea Polosan, Anamaria Bogdan, Raymund Schwan et al. · 2025 · Journal of Affective Disorders
  42. Enhancement of the endocannabinoid system through monoacylglycerol lipase inhibition relieves migraine-associated pain in mice
    Elizaveta Mangutov, Yaseen Awad-Igbaria, Kendra Siegersma, François Gastambide, Ayodeji A. Asuni, Amynah A. A. Pradhan · 2025 · The Journal of Headache and Pain
  43. The Role of Attachment Style, Adverse Childhood Experiences and Dissociation in Migraine
    Iain Mays, Jack Flynn, Brian E. McGuire, Jonathan Egan · 2021 · Journal of Trauma & Dissociation
  44. The Comparison of Pulsatility Index, Resistance Index, and Diameter of the Temporal, Carotid, and Vertebral Arteries During Active Migraine Headaches to Non-Headache Intervals
    Neda Akhoundi, Elmira Rezazadeh, Alireza Siami, Javad Komijani Bozchelouei, Mahtab Ramezani, Maryam Nosrati · 2023 · Journal of diagnostic medical sonography
  45. Frequency of migraine and its associated triggers and relievers among medical students of Lahore: a cross-sectional study
    Amna Liaquat, Wahab Azmat Sheikh, Iram Yousaf, Hassan Mumtaz, Maria Zafar, Aisha Haq Khan Sherwani · 2023 · Annals of Medicine and Surgery
  46. Modern strategies for the treatment of migraine attacks and the possibility of a differentiated approach
    Gyuzyal R. Tabeeva, O. V. Kosivtsova · 2023 · Meditsinskiy sovet = Medical Council
  47. Exploring Facial Thermography Patterns in Women with Chronic Migraine
    Bruno Veloso Fracasso, Renato Bender Castro, Marcos Leal Brioschi, Taís Malysz · 2023 · Journal of Clinical Medicine
  48. Prediction models for identifying medication overuse or medication overuse headache in migraine patients: a systematic review
    Teerapong Aramruang, Akshita Malhotra, Pawin Numthavaj, Panu Looareesuwan, Thunyarat Anothaisintawee, Charungthai Dejthevaporn, Nat Sirirutbunkajorn, John Attia, Ammarin Thakkinstian · 2024 · The Journal of Headache and Pain
  49. Typical clinical practice of treating patients with chronic migraine
    Veronika A. Golovacheva, Головачева Анжелика Александровна, A. R. Tarshilova, V. В. Osipova · 2024 · Neurology neuropsychiatry Psychosomatics
  50. Real-world use of over-the-counter medications by patients with migraine in Japan: results from the OVERCOME (Japan) 2nd study
    Ryotaro Ishii, Tsubasa Takizawa, Shiho Suzuki, Daisuke Danno, Moemi Miura, Yoshinori Tanizawa, Satoshi Osaga, Chie Hashimoto, Mika Komori · 2025 · The Journal of Headache and Pain
  51. Network dynamics mechanisms underlying the instigation and propagation of cortical spreading depression
    Chang He, Denggui Fan, Weiping Wang, Qingyun Wang, Gerold Baier · 2025 · Neurocomputing
  52. Headache disability, lifestyle factors, health perception, and mental disorder symptoms: a cross-sectional analysis of the 2013 National Health Survey in Brazil
    Arão Belitardo Oliveira, Juliane Prieto Peres Mercante, Isabela M. Benseñor, Alessandra Carvalho Goulart, Mário Fernando Prieto Peres · 2021 · Neurological Sciences
  53. The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis
    Jaime Fernández‐Bravo‐Rodrigo, Carlos Pascual‐Morena, Amparo Flor‐García, Alicia Saz‐Lara, Irene Sequí‐Domínguez, Celia Álvarez‐Bueno, Dolores Barreda-Hernández, Iván Cavero‐Redondo · 2022 · International Journal of Environmental Research and Public Health
  54. The evolving concept of multimorbidity and migraine
    Claudia Altamura, Gianluca Coppola, Fabrizio Vernieri · 2024 · Handbook of clinical neurology
  55. The processes underlying chronic migraine pathophysiology and its treatment with botulinum toxin type A
    Dominic Atraszkiewicz · 2021 · Neurology and Clinical Neuroscience
  56. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
    María Pilar Navarro‐Pérez, Vicente González‐Quintanilla, Albert Muñoz‐Vendrell, Elisabet Madrigal Lkhou, Alicia Alpuente, Germán Latorre, Francis Molina, María José Monzón, Vicente Medrano, David García‐Azorín et al. · 2024 · Frontiers in Neurology
  57. The economic burden of migraine: a nationwide cost-of-illness approach from the year 2020 European Health Survey in Spain
    José Fernández‐Ferro, Carlos Ordás, Javier Rejas, B Ferro-Rey, Susana Gómez-Lus, José Miguel Laínez Andrés · 2025 · Neurología (English Edition)
  58. Medication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nation
    Wanakorn Rattanawong, Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Auranee Trisataya, Sekh Thanprasertsuk, Alan M. Rapoport · 2025 · The Journal of Headache and Pain
  59. Decreased Serum Uric Acid Level as an Indicator of Altered Oxidative Balance in Patients With Migraine
    Sedat Yaşin, Erman Altunışık · 2022 · Cureus
  60. Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine
    Shane Root, Kevin Ahn, Jack Kirsch, Justin L. Hoskin · 2023 · Neuropsychiatric Disease and Treatment
  61. Cluster and network analysis of non-headache symptoms in migraine patients reveals distinct subgroups based on onset age and vestibular-cochlear symptom interconnection
    Hui Li, Xiaonuo Xu, Jiying Zhou, Liang Dong · 2023 · Frontiers in Neurology
  62. Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies
    Vinícius Lins Ferreira, Felipe Fernando Mainka, Astrid Wiens, Roberto Pontarolo · 2023 · Clinical Drug Investigation
  63. Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS)
    Agnete Skovlund Dissing, Xin Ying Lee, Ole Østerberg, Lene Hammer-Helmich · 2023 · Neurology and Therapy
  64. Association between awareness and knowledge of medication-overuse headache with medication-taking behavior among adults with migraine
    Stacy Cooper Bailey, Allison P. Pack, Andrea Zuleta, Wei Huang, Melissa P Herman, Steven M. Kymes, Damian Fiore, Yvonne Curran · 2024 · PLoS ONE
  65. Increased epicardial fat thickness and carotid intima–media thickness in migraine patients
    Hikmet Saçmacı, Yaşar Turan · 2019 · Neurological Sciences
  66. The association between migraine and glaucoma diseases: A retrospective cohort study
    Matan Bar, Ido Peles, Gal Ifergane, Erez Tsumi, Assaf Kratz · 2025 · Headache The Journal of Head and Face Pain
  67. Do Comorbidities and Triggers Expedite Chronicity in migraine?
    Emel Ur Özçeli̇k, Ezgi Uludüz, Rahşan Karacı, Füsun Mayda Domaç, Mustafa İskender, Aynur Özge, Derya Uludüz · 2023 · Neurological Sciences and Neurophysiology
  68. Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine
    Robert G. Kaniecki, Deborah Isa Friedman, Divya Asher, Joe Hirman, Roger K. Cady · 2023 · Pain and Therapy
  69. Study on the comprehensive treatment of migraine with traditional Chinese medicine based on the new pathophysiological mechanism: A review
    Yue Shen, Zeguang Li, Jing Wang, Zitong Qiu · 2024 · Medicine
  70. ”I am now on ‘speaking terms’ with my migraine monster” – patient experiences in acceptance-based cognitive behavioral therapy delivered via the internet for migraine: a randomized controlled pilot study using a mixed-method approach
    Marie Persson, Bledar Daka, Emma Varkey, Josefine Lotten Lilja, Linnea Nissling, Olena Cronstedt, Ann-Katrine Perschbacher, Anna Sofia Bratt, Sandra Weineland · 2024 · Cognitive Behaviour Therapy
  71. Treatment patterns, health resource consumption, and costs of patients with migraine in an Italian real-world setting
    Valentina Perrone, Chiara Veronesi, Elisa Giacomini, Margherita Andretta, Stefania Dell'orco, Giovambattista De Sarro, Fabio Lena, Anna Michela Menti, Mariantonietta Naclerio, Daniela Ritrovato et al. · 2020 · Current Medical Research and Opinion
  72. Efficacy of Adding a Distal Level Block to a C2 Level Greater Occipital Nerve Block under Ultrasound Guidance in Chronic Migraine
    Derya Güner, Şule Bilgin · 2023 · Annals of Indian Academy of Neurology
  73. Evaluation of the efficacy of preventive therapy in chronic migraine with or without medication overuse headache: data from a prospective study
    E. A. Guziy, А. В. Сергеев, Gyuzyal R. Tabeeva · 2024 · Neurology neuropsychiatry Psychosomatics
  74. Burden of disease and lifestyle habits in adolescents and young adults prone to frequent episodic migraine: A secondary comparative analysis
    Michaela Veronika Bonfert, Nico Sollmann, Tabea Renner, Corinna Börner, Giada Urban, Paul Schandelmaier, Iris Hannibal, Kristina Huß, Carmen Vita Parisi, Lucia Gerstl et al. · 2021 · Journal of Child Health Care
  75. Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis
    Emmanouil V. Dermitzakis, Michail Vikelis, George S. Vlachos, Andreas A. Argyriou · 2022 · Toxins
  76. Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic Migraine
    Emmanouil V. Dermitzakis, Michail Vikelis, George S. Vlachos, Andreas A. Argyriou · 2022 · Toxins
  77. Association of RAMP-1 gene polymorphisms and risk of migraine: Systemic review and meta-analysis
    Santhosh Kumar Yasam, Langeswaran Kulanthaivel, Kirubhanand Chandrasekaran, Priyanka Ganapathy, Gowtham Kumar Subbaraj · 2023 · Human Gene
  78. Clinical success of greater occipital nerve blockade in improving sleep quality of chronic migraineurs: a prospective observational study
    Hikmet Saçmacı, Tülin Aktürk, Nermin Tanık, Levent Ertuğrul İnan · 2021 · Sleep And Breathing
  79. Migraine-like headaches: a systematic review of secondary etiologies, clinical features and therapeutic patterns (1977–2024)
    Elliot Gabriel Gama-Reyes, Andrea Nuñez de Caceres-García, María F. Castillo-Vaca, Jacqueline Hernandez-Ramirez, Ariel E. Jimenez-Romo, Jenyfer María Fuentes‐Mendoza, Erika Rodríguez-Lizarraga, Carlos Andrés Díaz-Garza, Javier Andrés Galnares‐Olalde · 2025 · The Journal of Headache and Pain
  80. @HeadacheJournal Tweets On
    Matthew Stuart Robbins, Neda Shokrian, Todd J. Schwedt, Timothy T. Houle, Jason Roberts · 2019 · Headache The Journal of Head and Face Pain
  81. Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab
    Marco Bolchini, Francesca Schiano di Cola, Giulia Ceccardi, Salvatore Caratozzolo, Paolo Liberini, Renata Rao, Alessandro Padovani · 2022 · European Neurology
  82. Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta
    Suzanne McMullen, Erin Graves, John Paul Ekwaru, Tram Pham, Michelle Mayer, Marie-Pier Ladouceur, Martine Hubert, Joanna K. Bougie, Farnaz Amoozegar · 2023 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  83. New Daily Persistent Headache
    Matthew Stuart Robbins · 2024 · CONTINUUM Lifelong Learning in Neurology
  84. Migräne im Kindes- und Jugendalter – Ausblick auf innovative Behandlungsansätze im Rahmen multimodaler Therapiekonzepte
    Michaela Veronika Bonfert, Corinna Börner, Lucia Gerstl, Iris Hannibal, Nina Mathonia, Kristina Huß, Birte Rahmsdorf, Christina Kainz, Birgit Klose, Helene Koenig et al. · 2020 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  85. Migraine Progression: A Systematic Review. An Editorial Comment
    Dawn C. Buse, Jacob D. Greisman, Khosrow H. Baigi, Richard B. Lipton · 2019 · Headache The Journal of Head and Face Pain
  86. Caffeine as analgesic adjuvant
    Thomas W. Weiser · 2021 · Elsevier eBooks
  87. The wear-off phenomenon of repeated botulinum toxin injection for chronic migraine treatment: A retrospective study
    E. Rusen, Gaye Hafez, Yeşim Tunç · 2024 · Turkish Journal Of Neurology
  88. Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus
    Georgia Kourlaba, Michail Vikelis, Theodoros Karapanayiotides, Argyro Solakidi, Dimitrios T. Trafalis, Katerina Lioliou, Panagiotis Andriopoulos, Ασπασία Παναγιώτου, Dimos Dimitrios Mitsikostas · 2025 · Frontiers in Neurology
  89. Calcitonin gene-related peptide monoclonal antibodies and medication-overuse headache: stopping excessive pain medication is still necessary
    Pedro Augusto Sampaio Rocha‐Filho · 2025 · Arquivos de Neuro-Psiquiatria
  90. Migraine-related disability according to headache frequency subclassifications: A systematic review and meta-analysis
    Manjit Singh Matharu, Stephen D. Silberstein, Hsiangkuo Yuan, Deborah R. Edgar, Roos Colman, Todd J. Schwedt, Michel Lantéri‐Minet, Mark Obermann · 2025 · Cephalalgia
  91. Psychosocial factors as predictors of headache chronification: A systematic review and meta‐analysis of longitudinal studies
    Cornel H. M. Tol, Corine M. Visscher, Annemarie van der Wal, Naichuan Su, Hedwig A. van der Meer · 2025 · Headache The Journal of Head and Face Pain
  92. Comparative analysis of the efficacy of different treatment strategies in medication overuse headache: an open-label prospective trial
    А. В. Сергеев, E. A. Guziy, Ковальчук Надежда Александровна, E. A. Sokolov, G. V. Grigoriev, Gyuzyal R. Tabeeva · 2024 · Neurology neuropsychiatry Psychosomatics
  93. Disrupting Migraine Dynamics: A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody Therapies
    Dawn C. Buse, Jan J. Versijpt, Hans‐Christoph Diener · 2025 · Neurology and Therapy
  94. Migraine
    Edina Szabó, Rami Burstein, David Borsook · 2022 · Elsevier eBooks
  95. Real-world experience of OnabotulinumtoxinA treatment in female patients with chronic migraine: a qualitative study using in-depth interviews
    Domingo Palacios‐Ceña, Carlos Ordás, Javier Casas‐Limón, Jorge Pérez‐Corrales, Javier Güeita‐Rodríguez, José Antonio Arias Navalón, María L. Cuadrado · 2023 · Annals of Medicine
  96. Comparative efficacy and safety of different pharmacological therapies to medication overuse headache: a network meta-analysis
    Fanyi Kong, Dawn C. Buse, Guoliang Zhu, Jingjing Xu · 2024 · The Journal of Headache and Pain
  97. Optimizing the management of patients with chronic migraine and neck pain: a prospective randomized trial with long-term follow-up
    Veronika A. Golovacheva, Головачева Анжелика Александровна, Vladimir Anatolyevich Parfenov · 2025 · Russian neurological Journal
  98. Comorbidity in migraine
    Hisao Tachibana · 2022 · Rinsho Shinkeigaku
  99. Medication-overuse headache: clinical profile and management strategies
    Khalid Wasel Al-Quliti, Rakan Alhujeily · 2023 · Neurosciences
  100. Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcome
    Gabriel Bsteh, Stefan Macher, Nik Krajnc, Philip Pruckner, Wolfgang Marik, Christoph Mitsch, Klaus Novak, Berthold Pemp, Christian Wöber · 2022 · Research Square